copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Home | Ferrer For queries, to request medical information, become a partner, request an interview, report an adverse reaction or lodge a quality complaint, please leave us a message
Pharmaceuticals | Ferrer Ferrer's experience and knowledge make a difference in five treatment areas: pulmonary hypertension, the nervous system, pain, cardiometabolism, gastroenterology and dermatology In these areas, Ferrer offers trusted products that meet the highest European quality standards
Inicio - Ferrer Ferrer avanza en la investigación de la parálisis supranuclear progresiva (PSP) con la inclusión del primer participante en un ensayo clínico de fase II
Ferrer US Ferrer US is focused on the research and development of novel, proprietary products for the acute treatment of underserved medical needs, in the therapeutic areas of neurodegenerative disorders and pulmonary and interstitial lung disease
Productos farmacéuticos | Ferrer En Ferrer cubrimos todos los eslabones de la cadena de valor del medicamento y el producto farmacéutico, desde la investigación y el desarrollo, a la distribución y la comercialización, pasando por la compra y el aprovisionamiento
News - Ferrer Ferrer advances research into Progressive Supranuclear Palsy (PSP) with the inclusion of the first participant in a Phase II clinical trial
Ferrer México Ferrer México Mientras nuestra labor principal se centra en mejorar la salud y la calidad de vida, somos muy conscientes de la gran responsabilidad que tenemos con nuestro entorno y por eso estamos fuertemente comprometidos con la sostenibilidad social, medioambiental y económica
Ferrer obtains the distribution rights of a potential treatment for . . . The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agreement with United Therapeutics Corporation (Nasdaq: UTHR) for Tyvaso® (treprostinil inhalation solution*) – a pharmaceutical drug-device
Our history | Ferrer During the 60s, Ferrer becomes one of the most important companies in the Spanish market Internationalisation Ferrer starts its international expansion by means of acquisitions in Germany and by opening subsidiaries in Latin America
Ferrer Portugal Não obstante ter integrado a Ferrer em 2015, a Ferrer Portugal tem origem na mais antiga empresa farmacêutica portuguesa da história, a Companhia Portuguesa Higiene, fundada em 1891